Inhibition of proliferation, but not of Ca2+ mobilization, by cyclic AMP and GMP in rabbit aortic smooth-muscle cells
- 1 December 1992
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 288 (2) , 527-532
- https://doi.org/10.1042/bj2880527
Abstract
The effects on cellular proliferation and Ca2+ mobilization of analogues of cyclic AMP (cAMP) and cyclic GMP (cGMP) and of agents that elevate the intracellular concentrations of cyclic nucleotides were compared in closely similar preparations of first-passage rabbit aortic vascular smooth-muscle cells. Proliferation induced by foetal-bovine serum was inhibited by 78% by 1 mM-8-bromo cAMP and by 42% by 1 mM-8-bromo cGMP. In the presence of 100 microM-isobutylmethylxanthine, 100 microM-forskolin increased intracellular cAMP concentration 5-fold and inhibited proliferation by 87%, but did not affect cGMP concentration or cell viability (ATP concentration). Similarly in the presence of 100 microM-isobutylmethylxanthine, 1 mM-SIN-1 (3-morpholinosydnonimine) elevated cGMP concentration 4-fold and inhibited proliferation by 48%, but did not affect cAMP or ATP concentration. Isobutylmethylxanthine (1 mM) elevated cAMP concentration by 3-fold and cGMP concentration by 20-fold and inhibited proliferation by 81%. Concentrations of 8-bromo cAMP, 8-bromo cGMP, forskolin or SIN-1 that inhibited proliferation did not affect the elevation of intracellular free Ca2+ concentration caused by 2% (v/v) foetal-bovine serum, 100 nM-5-hydroxytryptamine or 10 nM-angiotensin II. The results demonstrate that elevation of intracellular cAMP and cGMP concentrations both independently inhibit vascular smooth-muscle cell proliferation, but these effects on proliferation are not mediated by inhibition of Ca2+ mobilization.Keywords
This publication has 43 references indexed in Scilit:
- A standardised method of culturing aortic explants, suitable for the study of factors affecting the phenotypic modulation, migration and proliferation of aortic smooth muscle cellsAtherosclerosis, 1991
- Effect of K252a, a protein kinase inhibitor, on the proliferation of vascular smooth muscle cellsBiochemical and Biophysical Research Communications, 1990
- Syndromes of accelerated atherosclerosis: Role of vascular injury and smooth muscle cell proliferationJournal of the American College of Cardiology, 1990
- Atrial natriuretic factor inhibits proliferation of vascular smooth muscle cells stimulated by platelet-derived growth factorBiochemical and Biophysical Research Communications, 1989
- Effects of protein kinase inhibitors on growth factor-stimulated DNA synthesis in cultured rat vascular smooth muscle cellsAtherosclerosis, 1988
- Independent inhibition of DNA synthesis by protein kinase C, cyclic AMP and interferon α/β in rabbit aortic smooth muscle cellsBiochemical and Biophysical Research Communications, 1988
- The use of fura-2 to determine the relationship between cytoplasmic free Ca2+ and oxidase activation in rat neutrophilsCell Calcium, 1988
- Possible involvement of protein kinase C in platelet-derived growth factor-stimulated DNA synthesis in vascular smooth muscle cellsAtherosclerosis, 1987
- Mechanism of vasodilation by molsidomineAmerican Heart Journal, 1985
- A common sequence of calcium and pH signals in the mitogenic stimulation of eukaryotic cellsNature, 1985